BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26113559)

  • 1. Overexpression of TRIM25 in Lung Cancer Regulates Tumor Cell Progression.
    Qin Y; Cui H; Zhang H
    Technol Cancer Res Treat; 2016 Oct; 15(5):707-15. PubMed ID: 26113559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retraction: Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer.
    Wang XL; Shi WP; Shi HC; Lu SC; Wang K; Sun C; He JS; Jin WG; Lv XX; Zou H; Shu YS
    Oncotarget; 2024 May; 15():312. PubMed ID: 38753318
    [No Abstract]   [Full Text] [Related]  

  • 3. Tripartite motif-containing protein 26 promotes colorectal cancer growth by inactivating p53.
    Lu H; Tan Z; Ko H; Naji P; Zhu R; Wang J; Huang S; Zhang YW; Zeng S
    Res Sq; 2024 Jan; ():. PubMed ID: 38260302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRTC1::TRIM11 cutaneous tumor: An update with local recurrence and lung metastasis in a pediatric patient.
    Vest BE; Berrebi KG; Stone MS; Sargen MR; Gerami P
    J Cutan Pathol; 2024 Mar; 51(3):181-183. PubMed ID: 37944913
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in the antitumor mechanisms of tripartite motif-containing protein 3.
    Teng W; Ling Y; Liu Z; Jiang L; Fu G; Zhou X; Long N; Liu J; Chu L
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):105. PubMed ID: 38411731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism governing RNA-binding property of mammalian TRIM71 protein.
    Shi F; Zhang K; Cheng Q; Che S; Zhi S; Yu Z; Liu F; Duan F; Wang Y; Yang N
    Sci Bull (Beijing); 2024 Jan; 69(1):72-81. PubMed ID: 38036331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.
    Takayama KI; Suzuki T; Tanaka T; Fujimura T; Takahashi S; Urano T; Ikeda K; Inoue S
    Oncogene; 2018 Apr; 37(16):2165-2180. PubMed ID: 29379164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF-β signaling.
    Zhu Z; Wang Y; Zhang C; Yu S; Zhu Q; Hou K; Yan B
    Sci Rep; 2016 Jan; 6():19070. PubMed ID: 26754079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer.
    Wang S; Kollipara RK; Humphries CG; Ma SH; Hutchinson R; Li R; Siddiqui J; Tomlins SA; Raj GV; Kittler R
    Oncotarget; 2016 Oct; 7(40):64921-64931. PubMed ID: 27626314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Trim25 in development, disease and RNA metabolism.
    Heikel G; Choudhury NR; Michlewski G
    Biochem Soc Trans; 2016 Aug; 44(4):1045-50. PubMed ID: 27528750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway.
    Liu Y; Tao S; Liao L; Li Y; Li H; Li Z; Lin L; Wan X; Yang X; Chen L
    Nat Commun; 2020 Jan; 11(1):348. PubMed ID: 31953436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
    Zang HL; Ren SN; Cao H; Tian XF
    IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of miR-3614 maturation by IGF2BP3 increases TRIM25 expression and promotes breast cancer cell proliferation.
    Wang Z; Tong D; Han C; Zhao Z; Wang X; Jiang T; Li Q; Liu S; Chen L; Chen Y; Li A; Huang C
    EBioMedicine; 2019 Mar; 41():357-369. PubMed ID: 30797711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of TRIM25 as a Negative Regulator of Caspase-2 Expression Reveals a Novel Target for Sensitizing Colon Carcinoma Cells to Intrinsic Apoptosis.
    Nasrullah U; Haeussler K; Biyanee A; Wittig I; Pfeilschifter J; Eberhardt W
    Cells; 2019 Dec; 8(12):. PubMed ID: 31842382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MAP3K13-TRIM25-FBXW7α axis affects c-Myc protein stability and tumor development.
    Zhang Q; Li X; Cui K; Liu C; Wu M; Prochownik EV; Li Y
    Cell Death Differ; 2020 Feb; 27(2):420-433. PubMed ID: 31186535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.
    Sato W; Ikeda K; Urano T; Abe Y; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
    PLoS One; 2018; 13(12):e0208351. PubMed ID: 30586414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OTUD5 cooperates with TRIM25 in transcriptional regulation and tumor progression via deubiquitination activity.
    Li F; Sun Q; Liu K; Zhang L; Lin N; You K; Liu M; Kon N; Tian F; Mao Z; Li T; Tong T; Qin J; Gu W; Li D; Zhao W
    Nat Commun; 2020 Aug; 11(1):4184. PubMed ID: 32826889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
    Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
    J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tripartite motif protein 25 is associated with epirubicin resistance in hepatocellular carcinoma cells via regulating PTEN/AKT pathway.
    Yuan P; Zheng A; Tang Q
    Cell Biol Int; 2020 Jul; 44(7):1503-1513. PubMed ID: 32196840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM25 in the Regulation of the Antiviral Innate Immunity.
    Martín-Vicente M; Medrano LM; Resino S; García-Sastre A; Martínez I
    Front Immunol; 2017; 8():1187. PubMed ID: 29018447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.